发明授权
- 专利标题： Compound for increasing kinase active and application thereof
- 专利标题（中）： 增加激酶活性的化合物及其应用
-
申请号： US13884470申请日： 2011-11-09
-
公开(公告)号： US09409900B2公开(公告)日： 2016-08-09
- 发明人: Xinshan Kang , Wei Long , Cunbo Ma , Yanping Wang , Xiaoyan Shen , Yunyan Hu , Fenlai Tan , Yinxiang Wang
- 申请人： Xinshan Kang , Wei Long , Cunbo Ma , Yanping Wang , Xiaoyan Shen , Yunyan Hu , Fenlai Tan , Yinxiang Wang
- 申请人地址： CN Fuzhou, Fujian CN Hangzhou, Zhejiang CN Beijing
- 专利权人： FUJIAN HAIXI PHARMACEUTICALS, INC.,BETTA PHARMACUETICALS CO., LTD.,Xinshan Kang
- 当前专利权人： FUJIAN HAIXI PHARMACEUTICALS, INC.,BETTA PHARMACUETICALS CO., LTD.,Xinshan Kang
- 当前专利权人地址： CN Fuzhou, Fujian CN Hangzhou, Zhejiang CN Beijing
- 代理机构： RatnerPrestia
- 优先权： CN201010535640 20101109
- 国际申请： PCT/CN2011/082004 WO 20111109
- 国际公布： WO2012/062210 WO 20120518
- 主分类号： C07D417/12
- IPC分类号： C07D417/12 ; C07D233/88 ; C07D405/14 ; C07D417/14 ; C07D213/74 ; C07D213/80 ; C07D213/803 ; C07D241/20 ; C07D277/42 ; C07D285/08 ; C07D401/12 ; C07D403/12 ; C07D405/04 ; C07D405/12 ; C07D401/14
摘要：
The compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, chelates thereof, non-covalent complexes thereof or produgs of compounds mentioned above or the mixture of any form above mentioned are provided. The use of the compounds in manufacturing a medicament for the treatment and/or prevention of diabetes, obesity and related disorders.